Cargando…

Cardiovascular imaging: what have we learned from animal models?

Cardiovascular imaging has become an indispensable tool for patient diagnosis and follow up. Probably the wide clinical applications of imaging are due to the possibility of a detailed and high quality description and quantification of cardiovascular system structure and function. Also phenomena tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Arnoldo, Fernández-Friera, Leticia, Villalba, María, López-Melgar, Beatriz, España, Samuel, Mateo, Jesús, Mota, Ruben A., Jiménez-Borreguero, Jesús, Ruiz-Cabello, Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612690/ https://www.ncbi.nlm.nih.gov/pubmed/26539113 http://dx.doi.org/10.3389/fphar.2015.00227

Ejemplares similares

Assessment of regional pulmonary blood flow using (68)Ga-DOTA PET
por: Velasco, Carlos, et al.
Publicado: (2017)

Augmented Renal Clearance: What Have We Known and What Will We Do?
por: Luo, Yifan, et al.
Publicado: (2021)

What have we learned ventilating COVID-19 patients?
por: Trahtemberg, Uriel, et al.
Publicado: (2020)

The need for better AD animal models
por: Medina, Miguel, et al.
Publicado: (2014)

What have we learned from brucellosis in the mouse model?
por: Grilló, María-Jesús, et al.
Publicado: (2012)

Understanding Molecular Landscape of Endometrial Cancer through Next Generation Sequencing: What We Have Learned so Far?
por: Suhaimi, Siti-Syazani, et al.
Publicado: (2016)

Explicit measurement of multi-tracer arterial input function for PET imaging using blood sampling spectroscopy
por: Velasco, Carlos, et al.
Publicado: (2020)

Development of a blood sample detector for multi-tracer positron emission tomography using gamma spectroscopy
por: Velasco, Carlos, et al.
Publicado: (2019)

Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
por: Conde, João, et al.
Publicado: (2016)

“Tau Oligomers,” What We Know and What We Don’t Know
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
por: Delire, Bénédicte, et al.
Publicado: (2015)

Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms
por: Lazaro, Iolanda, et al.
Publicado: (2018)

Hyperoxia and Lungs: What We Have Learned From Animal Models
por: Amarelle, Luciano, et al.
Publicado: (2021)

What have we learned about COVID-19 volunteering in the UK? A rapid review of the literature
por: Mao, Guanlan, et al.
Publicado: (2021)

PTH Assays: Understanding What We Have and Forecasting What We Will Have
por: Vieira, Jose Gilberto H.
Publicado: (2012)

What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?
por: Lacroix, Clémence, et al.
Publicado: (2022)

Pharmacological Intervention to Modulate HDL: What Do We Target?
por: Woudberg, Nicholas J., et al.
Publicado: (2018)

Contextualising the Perceptions of Pharmacists Practicing Clinical Pharmacy in South Africa—Do We Practice what We Preach?
por: Bronkhorst, Elmien, et al.
Publicado: (2021)

Immunoglobulin genes and diversity: what we have learned from domestic animals
por: Sun, Yi, et al.
Publicado: (2012)

Activation of amino acid metabolic program in cardiac HIF1-alpha-deficient mice
por: Menendez-Montes, Ivan, et al.
Publicado: (2021)

What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021)

Acute severe hepatitis outbreak in children: A perfect storm. What do we know, and what questions remain?
por: Matthews, Philippa C., et al.
Publicado: (2022)

Psychological Interventions for Dementia Caregivers: What We Have Achieved, What We Have Learned
por: Cheng, Sheung-Tak, et al.
Publicado: (2019)

Lipoabdominoplasty: What We Have Implemented and What We Have Modified over 26 Years
por: Cárdenas-Camarena, Lázaro, et al.
Publicado: (2023)

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models
por: Samsom, James N., et al.
Publicado: (2015)

Innate immunity and chronic rhinosinusitis: What we have learned from animal models
por: London, Nyall R., et al.
Publicado: (2016)

What have we learned from animal models of ventilator-induced lung injury?
por: Rocco, Patricia Rieken Macedo, et al.
Publicado: (2020)

Large Animal Models of Huntington’s Disease: What We Have Learned and Where We Need to Go Next
por: Howland, David, et al.
Publicado: (2020)

Population Equation: Balancing What We Need With What We Have
por: Dahl, Richard
Publicado: (2005)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

Artificial Intelligence in Urooncology: What We Have and What We Expect
por: Froń, Anita, et al.
Publicado: (2023)

What have we done in our anesthesia ICU to maintain communication in the pandemic?()
por: Mateo Rodríguez, E., et al.
Publicado: (2020)

An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
por: Indari, Omkar, et al.
Publicado: (2021)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far
por: Flores, África, et al.
Publicado: (2013)

Multidisciplinary management in chronic myeloid leukemia improves cardiovascular risk measured by SCORE
por: Blanco Sánchez, Alberto, et al.
Publicado: (2023)

GOAL: What Have We Learned?
por: Leek, Timothy K Vander
Publicado: (2005)

What have we learned on mesons?
por: Moebes, J P
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_49sv19n5kr9hu0ptnnao7fgdua